Healthcare | May 25, 2026
Zota Health Care posts 83.86% revenue surge in FY26
Expands Davaindia network to 2,579 stores
Expands Davaindia network to 2,579 stores
The approval was granted by Agenzia Italiana del Farmaco
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Access to genomic testing, not therapy cost, is the biggest challenge
Subscribe To Our Newsletter & Stay Updated
